435 related articles for article (PubMed ID: 31678275)
1. Potential clinical applications of the personalized, disease-specific protein corona on nanoparticles.
García Vence M; Chantada-Vázquez MDP; Vázquez-Estévez S; Manuel Cameselle-Teijeiro J; Bravo SB; Núñez C
Clin Chim Acta; 2020 Feb; 501():102-111. PubMed ID: 31678275
[TBL] [Abstract][Full Text] [Related]
2. Personalized protein corona on nanoparticles and its clinical implications.
Corbo C; Molinaro R; Tabatabaei M; Farokhzad OC; Mahmoudi M
Biomater Sci; 2017 Feb; 5(3):378-387. PubMed ID: 28133653
[TBL] [Abstract][Full Text] [Related]
3. How protein coronas determine the fate of engineered nanoparticles in biological environment.
Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
[TBL] [Abstract][Full Text] [Related]
4. The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.
Liu N; Tang M; Ding J
Chemosphere; 2020 Apr; 245():125624. PubMed ID: 31864050
[TBL] [Abstract][Full Text] [Related]
5. Effect of protein corona magnetite nanoparticles derived from bread in vitro digestion on Caco-2 cells morphology and uptake.
Di Silvio D; Rigby N; Bajka B; Mackie A; Baldelli Bombelli F
Int J Biochem Cell Biol; 2016 Jun; 75():212-22. PubMed ID: 26520468
[TBL] [Abstract][Full Text] [Related]
6. Protein Nanoparticle Charge and Hydrophobicity Govern Protein Corona and Macrophage Uptake.
Pustulka SM; Ling K; Pish SL; Champion JA
ACS Appl Mater Interfaces; 2020 Oct; 12(43):48284-48295. PubMed ID: 33054178
[TBL] [Abstract][Full Text] [Related]
7. Understanding the Factors Influencing Chitosan-Based Nanoparticles-Protein Corona Interaction and Drug Delivery Applications.
Moraru C; Mincea M; Menghiu G; Ostafe V
Molecules; 2020 Oct; 25(20):. PubMed ID: 33081296
[TBL] [Abstract][Full Text] [Related]
8. A health concern regarding the protein corona, aggregation and disaggregation.
Falahati M; Attar F; Sharifi M; Haertlé T; Berret JF; Khan RH; Saboury AA
Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):971-991. PubMed ID: 30802594
[TBL] [Abstract][Full Text] [Related]
9. Cancer Nano-Immunotherapy from the Injection to the Target: The Role of Protein Corona.
Mikelez-Alonso I; Aires A; Cortajarena AL
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947622
[TBL] [Abstract][Full Text] [Related]
10. Disease-related metabolites affect protein-nanoparticle interactions.
Tavakol M; Montazeri A; Naghdabadi R; Hajipour MJ; Zanganeh S; Caracciolo G; Mahmoudi M
Nanoscale; 2018 Apr; 10(15):7108-7115. PubMed ID: 29616243
[TBL] [Abstract][Full Text] [Related]
11. The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system.
Xiao W; Gao H
Int J Pharm; 2018 Dec; 552(1-2):328-339. PubMed ID: 30308270
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence correlation spectroscopy as a tool for the study of the intracellular dynamics and biological fate of protein corona.
Martinez-Moro M; Di Silvio D; Moya SE
Biophys Chem; 2019 Oct; 253():106218. PubMed ID: 31325709
[TBL] [Abstract][Full Text] [Related]
13. Proteomic and Lipidomic Analysis of Nanoparticle Corona upon Contact with Lung Surfactant Reveals Differences in Protein, but Not Lipid Composition.
Raesch SS; Tenzer S; Storck W; Rurainski A; Selzer D; Ruge CA; Perez-Gil J; Schaefer UF; Lehr CM
ACS Nano; 2015 Dec; 9(12):11872-85. PubMed ID: 26575243
[TBL] [Abstract][Full Text] [Related]
14. Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System.
Barbero F; Russo L; Vitali M; Piella J; Salvo I; Borrajo ML; Busquets-Fité M; Grandori R; Bastús NG; Casals E; Puntes V
Semin Immunol; 2017 Dec; 34():52-60. PubMed ID: 29066063
[TBL] [Abstract][Full Text] [Related]
15. Influence of dynamic flow environment on nanoparticle-protein corona: From protein patterns to uptake in cancer cells.
Palchetti S; Pozzi D; Capriotti AL; Barbera G; Chiozzi RZ; Digiacomo L; Peruzzi G; Caracciolo G; Laganà A
Colloids Surf B Biointerfaces; 2017 May; 153():263-271. PubMed ID: 28273493
[TBL] [Abstract][Full Text] [Related]
16. Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles.
Francia V; Yang K; Deville S; Reker-Smit C; Nelissen I; Salvati A
ACS Nano; 2019 Oct; 13(10):11107-11121. PubMed ID: 31525954
[TBL] [Abstract][Full Text] [Related]
17. Intentional formation of a protein corona on nanoparticles: Serum concentration affects protein corona mass, surface charge, and nanoparticle-cell interaction.
Gräfe C; Weidner A; Lühe MV; Bergemann C; Schacher FH; Clement JH; Dutz S
Int J Biochem Cell Biol; 2016 Jun; 75():196-202. PubMed ID: 26556312
[TBL] [Abstract][Full Text] [Related]
18. Dispersion of Nanoparticles in Different Media Importantly Determines the Composition of Their Protein Corona.
Strojan K; Leonardi A; Bregar VB; Križaj I; Svete J; Pavlin M
PLoS One; 2017; 12(1):e0169552. PubMed ID: 28052135
[TBL] [Abstract][Full Text] [Related]
19. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
[TBL] [Abstract][Full Text] [Related]
20. The importance of selecting a proper biological milieu for protein corona analysis in vitro: Human plasma versus human serum.
Mirshafiee V; Kim R; Mahmoudi M; Kraft ML
Int J Biochem Cell Biol; 2016 Jun; 75():188-95. PubMed ID: 26643610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
